Your browser doesn't support javascript.
loading
SLE and multiple myeloma: an underlooked link? A review of case reports from the last decade.
Desai, Rupak; Devaragudi, Sanjana; Kaur, Loveneet; Singh, Kulwinder; Bawa, Jerrin; Theik, Nyein Wint Yee; Palisetti, Spandana; Jain, Akhil.
Afiliación
  • Desai R; Independent Researcher, Atlanta, GA, USA.
  • Devaragudi S; Department of Medicine, Apollo Institute of Medical Sciences and Research, Hyderabad, India.
  • Kaur L; Department of Medicine, Government Medical College, Patiala, India.
  • Singh K; Department of Medicine, Government Medical College, Patiala, India.
  • Bawa J; Department of Internal Medicine, Flushing Hospital Medical Center, NY, USA.
  • Theik NWY; Department of Internal Medicine, Memorial Healthcare System, Hollywood, FL, USA.
  • Palisetti S; Department of Medicine, Jawaharlal Nehru Medical College, Belagavi, Karnataka, India.
  • Jain A; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
J Med Life ; 17(2): 141-146, 2024 Feb.
Article en En | MEDLINE | ID: mdl-38813361
ABSTRACT
Systemic lupus erythematosus (SLE) affects multiple organ systems, and there has recently been increasing evidence that suggests a considerable rise in cancer risk. Despite growing evidence, the relationship between SLE and multiple myeloma (MM) remains underlooked. This review synthesizes findings from case reports published between 2012 and 2023 to explore this relationship. We conducted a comprehensive search using PubMed, Embase, and Google Scholar with the keywords 'SLE' and 'multiple myeloma' and described the clinical profile of MM in patients with SLE. Seven case reports were reviewed. Five case reports included female participants, two had a simultaneous diagnosis of SLE and MM, and in others, MM followed SLE varying from 7 months to 30 years. Two cases reported an improvement in MM. Four cases reported death due to complications, which included shock, myocardial infarction, and pneumonia. Lupus nephritis was seen to complicate MM and SLE complex in 2 cases. Larger, well-developed studies focusing on clinical presentation, diagnostic strategy, treatment, and outcomes are needed to better understand the association between SLE and MM. Healthcare workers should be aware of the increased risk of malignancy in SLE and customize screening accordingly.
Asunto(s)
Palabras clave

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Lupus Eritematoso Sistémico / Mieloma Múltiple Límite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: J Med Life Asunto de la revista: MEDICINA Año: 2024 Tipo del documento: Article País de afiliación: Estados Unidos

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Lupus Eritematoso Sistémico / Mieloma Múltiple Límite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: J Med Life Asunto de la revista: MEDICINA Año: 2024 Tipo del documento: Article País de afiliación: Estados Unidos